Health

Drug Approval Delay Scrutinized

Updated 2026-07-09 10:40 UTC 1 source Negative

Regulatory approval for Northwest Biotherapeutics' brain cancer treatment has been pending for over two years. Critics argue this delay may indicate a broader issue within the drug approval process.

Coverage timeline — 1 article

STAT News

STAT+: 931 days. The drug approval scandal hiding in plain sight

Two years, six months, and 18 days have elapsed since Northwest Biotherapeutics submitted its brain cancer treatment for regulatory approval.

2026-07-09 10:30 UTC